🇺🇸 FDA
Patent

US 7368100

Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same

granted A61KA61K51/1051A61P

Quick answer

US patent 7368100 (Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and methods of using same) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K51/1051, A61P, A61P35/00